These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8073539)

  • 1. Androgen receptors and hormone sensitivity of a human prostatic cancer cell line (PC-3) are modulated by natural beta-interferon.
    Sica G; Dell'Acqua G; Iacopino F; Fattorossi A; Marchetti P; van der Kwast TH; Pavone-Macaluso M
    Urol Res; 1994; 22(1):33-8. PubMed ID: 8073539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synthetic androgen mibolerone induces transient suppression of the transformed phenotype in an androgen responsive human prostatic carcinoma cell line.
    Schulz P; Wolf D; Arbusow V; Bojar H; Klobeck HG; Fittler F
    Andrologia; 1990; 22 Suppl 1():56-66. PubMed ID: 2151880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of mutant androgen receptors by flutamide.
    Ishioka J; Hara S; Isaacs JT; Tomura A; Nishikawa K; Kageyama Y
    Int J Urol; 2009 May; 16(5):516-21. PubMed ID: 19389135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve growth factor induces the re-expression of functional androgen receptors and p75(NGFR) in the androgen-insensitive prostate cancer cell line DU145.
    Sigala S; Tognazzi N; Rizzetti MC; Faraoni I; Missale C; Bonmassar E; Spano P
    Eur J Endocrinol; 2002 Sep; 147(3):407-15. PubMed ID: 12213679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity.
    Wang LG; Liu XM; Kreis W; Budman DR
    Biochem Biophys Res Commun; 1999 May; 259(1):21-8. PubMed ID: 10334909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor.
    Heisler LE; Evangelou A; Lew AM; Trachtenberg J; Elsholtz HP; Brown TJ
    Mol Cell Endocrinol; 1997 Jan; 126(1):59-73. PubMed ID: 9027364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.
    Fenton MA; Shuster TD; Fertig AM; Taplin ME; Kolvenbag G; Bubley GJ; Balk SP
    Clin Cancer Res; 1997 Aug; 3(8):1383-8. PubMed ID: 9815822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steroidal antiandrogens act as AF-1 agonists under conditions of high androgen-receptor expression.
    Fuse H; Korenaga S; Sakari M; Hiyama T; Ito T; Kimura K; Kato S
    Prostate; 2007 May; 67(6):630-7. PubMed ID: 17342748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen independence of primary epithelial cultures of the prostate is associated with a down-regulation of androgen receptor gene expression.
    Grant ES; Batchelor KW; Habib FK
    Prostate; 1996 Dec; 29(6):339-49. PubMed ID: 8977630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations.
    Lyng FM; Jones GR; Rommerts FF
    Biol Reprod; 2000 Sep; 63(3):736-47. PubMed ID: 10952915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen and epidermal growth factor down-regulate cyclin-dependent kinase inhibitor p27Kip1 and costimulate proliferation of MDA PCa 2a and MDA PCa 2b prostate cancer cells.
    Ye D; Mendelsohn J; Fan Z
    Clin Cancer Res; 1999 Aug; 5(8):2171-7. PubMed ID: 10473102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
    Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C
    Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells.
    Godoy-Tundidor S; Hobisch A; Pfeil K; Bartsch G; Culig Z
    Clin Cancer Res; 2002 Jul; 8(7):2356-61. PubMed ID: 12114440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.
    Andrieu T; Bertolini R; Nichols SE; Setoud R; Frey FJ; Baker ME; Frey BM
    Biochem Pharmacol; 2011 Dec; 82(11):1651-62. PubMed ID: 21907706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen regulation of parathyroid hormone-related peptide production in human prostate cancer cells.
    Pizzi H; Gladu J; Carpio L; Miao D; Goltzman D; Rabbani SA
    Endocrinology; 2003 Mar; 144(3):858-67. PubMed ID: 12586762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression changes and regulation of AR and IGF-1 in PC3 prostate cancer cells treated with sexual hormones and flutamide.
    Tong da Y; Wu Xy; Sun Hy; Jin Y; Liu Zw; Zhou Fj
    Tumour Biol; 2012 Dec; 33(6):2151-8. PubMed ID: 22935919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for androgen receptor gene expression and growth inhibitory effect of dihydrotestosterone on human adrenocortical cells.
    Rossi R; Zatelli MC; Valentini A; Cavazzini P; Fallo F; del Senno L; degli Uberti EC
    J Endocrinol; 1998 Dec; 159(3):373-80. PubMed ID: 9834454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen.
    Takeda K; Hara N; Nishiyama T; Tasaki M; Ishizaki F; Tomita Y
    BMC Cancer; 2016 May; 16():332. PubMed ID: 27225190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP.
    Olea N; Sakabe K; Soto AM; Sonnenschein C
    Endocrinology; 1990 Mar; 126(3):1457-63. PubMed ID: 2307113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.
    Lucia MS; Sporn MB; Roberts AB; Stewart LV; Danielpour D
    J Cell Physiol; 1998 May; 175(2):184-92. PubMed ID: 9525477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.